Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging
NCT ID: NCT03097822
Last Updated: 2017-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study
NCT01938677
Evolution of Cochleovestibular Schwannomas
NCT04417868
Vestibular Evaluation After Vestibular Schwannoma Treatment
NCT03670589
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
NCT06112509
Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
NCT02249572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with vestibular schwannoma, who received consent
Exclusion Criteria
* During the observation period, other treatments were performed other than gamma knife surgery
* If patients have a contraindication to MRI (eg, pacemaker, cochlear implants, hemodynamically unstable)
* Concomitant use of gadolinium MRI contrast agents (eg, renal insufficiency \[glomerular filtration rate \<30 ML / min\]), or if there was a side effect when using a contrast medium.
* Adults with impaired ability to cope
* If the images and medical records required for this study are not available or are not appropriate
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung Hong Choi
SeoulNUH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SeungHong Choi, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital(Radiology)
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-1611-087-809
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.